- Home
- COE vs PMVP Comparison
COE vs PMVP Comparison
Compare COE & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- PMVP
- Stock Information
- Founded
- COE 2011
- PMVP 2013
- Country
- COE Singapore
- PMVP United States
- Employees
- COE N/A
- PMVP N/A
- Industry
- COE Other Consumer Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- COE Real Estate
- PMVP Health Care
- Exchange
- COE Nasdaq
- PMVP Nasdaq
- Market Cap
- COE 91.5M
- PMVP 85.5M
- IPO Year
- COE 2016
- PMVP 2020
- Fundamental
- Price
- COE $14.20
- PMVP $1.61
- Analyst Decision
- COE
- PMVP Strong Buy
- Analyst Count
- COE 0
- PMVP 4
- Target Price
- COE N/A
- PMVP $5.75
- AVG Volume (30 Days)
- COE 5.1K
- PMVP 209.2K
- Earning Date
- COE 12-16-2024
- PMVP 11-07-2024
- Dividend Yield
- COE N/A
- PMVP N/A
- EPS Growth
- COE N/A
- PMVP N/A
- EPS
- COE N/A
- PMVP N/A
- Revenue
- COE $35,705,000.00
- PMVP N/A
- Revenue This Year
- COE N/A
- PMVP N/A
- Revenue Next Year
- COE N/A
- PMVP N/A
- P/E Ratio
- COE N/A
- PMVP N/A
- Revenue Growth
- COE 66.41
- PMVP N/A
- 52 Week Low
- COE $6.00
- PMVP $1.40
- 52 Week High
- COE $19.75
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- COE 41.35
- PMVP 47.86
- Support Level
- COE $14.01
- PMVP $1.59
- Resistance Level
- COE $15.00
- PMVP $1.82
- Average True Range (ATR)
- COE 0.56
- PMVP 0.07
- MACD
- COE -0.13
- PMVP -0.01
- Stochastic Oscillator
- COE 8.88
- PMVP 8.70
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.